Why the study?
Clinical experience with leadless pacemaker implantation in young children remains scarce, and patients with 22q11.2 deletion syndrome are susceptible to conduction abnormalities and severe hypersensitivity reactions to conventional transvenous pacing devices.
Population
A 4-year-old child in China with 22q11.2 deletion syndrome and third-degree atrioventricular block
Design
Case report
Answers are grounded in this paper and cite their sources.
Supports leadless pacemaker consideration in pediatric metal hypersensitivity; leaves open validation in 22q11.2 deletion syndrome.
Leadless pacemaker implantation represents an emerging therapeutic alternative for patients ineligible for conventional pacing systems; nevertheless, clinical experience in young children remains scarce. Individuals with 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) are susceptible to conduction abnormalities and severe hypersensitivity reactions to transvenous pacing devices. Herein, we report the youngest documented case in China of successful leadless pacemaker implantation in a 4-year-old child presenting with third-degree atrioventricular block, who developed severe nickel-titanium hypersensitivity following three prior conventional pacemaker implantations. This case report describes our perioperative nursing management and provides clinical insights to facilitate care for similarly complex paediatric patients.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: